Related references
Note: Only part of the references are listed.A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
Richard M Bergenstal et al.
LANCET (2021)
The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes
John M. Lachin et al.
DIABETES CARE (2021)
Immunotherapy: Building a bridge to a cure for type 1 diabetes
Jeffrey A. Bluestone et al.
SCIENCE (2021)
Strategies for durable β cell replacement in type 1 diabetes
Todd M. Brusko et al.
SCIENCE (2021)
Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
Charlotte Boughton et al.
BMJ OPEN (2020)
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
Marc D. Breton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery
Klemen Dovc et al.
DIABETES CARE (2019)
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
S. A. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Martin Tauschmann et al.
LANCET (2018)
Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes
Yue Ruan et al.
DIABETES CARE (2016)
Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
John M. Lachin et al.
DIABETES (2014)
Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes
Bruce Buckingham et al.
DIABETES CARE (2013)
Glycaemic Variability and Pancreatic beta-cell Dysfunction
Klaus-Dieter Kohnert et al.
CURRENT DIABETES REVIEWS (2012)
Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis
Henrik B. Mortensen et al.
PEDIATRIC DIABETES (2010)
Preservation of β-Cell Function in Autoantibody-Positive Youth With Diabetes
Carla J. Greenbaum et al.
DIABETES CARE (2009)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)